Literature DB >> 16406079

Interleukin-18/-607 gene polymorphism in allergic rhinitis.

Heung-Man Lee1, Sook Ah Park, Seung-Won Chung, Jeong Soo Woo, Sung Won Chae, Sang Hag Lee, Hee Joon Kang, Soon Jae Hwang.   

Abstract

OBJECTIVES: Allergic rhinitis is a chronic inflammatory disease with a genetic background, and IL-18 (formerly IFN-gamma-inducing factor) is a well-known pro-inflammatory cytokine. The aim of this study was to investigate whether the IL-18/-607 promoter polymorphisms were associated with allergic rhinitis in the Korean population. STUDY
DESIGN: Prospective study.
METHODS: Deoxyribonucleic acid was obtained from the blood samples of 160 Korean children with allergic rhinitis and from 166 healthy controls. The IL-18/-607 polymorphism was analyzed by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis.
RESULTS: The frequency of the AC genotype of the IL-18/-607 gene polymorphism was significantly greater in allergic rhinitis patients than in controls (P<0.05).
CONCLUSIONS: The A allele in the IL-18/-607 gene promoter region may be involved in the development of allergic rhinitis in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406079     DOI: 10.1016/j.ijporl.2005.11.006

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  11 in total

1.  -607 C/A polymorphism in the promoter of IL-18 gene is associated with 2 h post-loading plasma glucose level in Chinese.

Authors:  Yun Huang; Min Xu; Jie Hong; Weiqiong Gu; Yufang Bi; Xiaoying Li
Journal:  Endocrine       Date:  2010-04-13       Impact factor: 3.633

Review 2.  Role of interleukin-18 in the pathophysiology of allergic diseases.

Authors:  Nathan L Sanders; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2016-07-15       Impact factor: 7.638

3.  IL-18 genetic polymorphisms may contribute to the pathogenesis of tuberculosis among Asians: a meta-analysis of case-control studies.

Authors:  Xiao-Ling Yu; Fei Zhao; Jun Zhang; Xiao-Ming Pan
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

4.  Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Collins Ouma; Tom Were; Gregory C Davenport; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

5.  Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients.

Authors:  K Manohar; P V Suneetha; Nirupama Trehan Pati; Abhishek C Gupta; Syed Hissar; Puja Sakhuja; S K Sarin
Journal:  Hepatol Int       Date:  2009-03-17       Impact factor: 6.047

6.  A meta-analysis of Th2 pathway genetic variants and risk for allergic rhinitis.

Authors:  Supinda Bunyavanich; Josef Shargorodsky; Juan C Celedón
Journal:  Pediatr Allergy Immunol       Date:  2011-02-10       Impact factor: 6.377

7.  Treatment trends in allergic rhinitis and asthma: a British ENT survey.

Authors:  Ravinder S Natt; Petros D Karkos; Davinia K Natt; Eva G Theochari; Apostolos Karkanevatos
Journal:  BMC Ear Nose Throat Disord       Date:  2011-04-11

8.  The association between IL18, FOXP3 and IL13 genes polymorphisms and risk of allergic rhinitis: a meta-analysis.

Authors:  Liang Tang; Yongjun Chen; Qin Xiang; Ju Xiang; Yonghong Tang; Jianming Li
Journal:  Inflamm Res       Date:  2020-06-11       Impact factor: 6.986

9.  Correlation between interleukin-18 promoter -607C/A polymorphism and susceptibility to ischemic stroke.

Authors:  Jian-xia Lu; Zhong-qian Lu; Shao-lan Zhang; Juan Zhi; Zheng-ping Chen; Wan-xiang Wang
Journal:  Braz J Med Biol Res       Date:  2013-05-24       Impact factor: 2.590

Review 10.  The relationship between interleukin-18 polymorphisms and allergic disease: a meta-analysis.

Authors:  Daye Cheng; Yiwen Hao; Wenling Zhou; Yiran Ma
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.